CIMC ENRIC (03899) publishes its interim results, with profits attributable to equity holders of approximately 562 million yuan, representing a year-on-year increase of 15.6%.
China National Refresh Technology (03899) announced its performance for the mid-term of 2025, with revenue of approximately 12.614 billion yuan, a year-on-year growth of 9...
CIMC ENRIC (03899) announces its mid-term performance for 2025, with revenue of approximately 12.614 billion yuan, an increase of 9.9% year-on-year; the profit attributable to equity holders is about 562 million yuan, up 15.6% year-on-year; basic earnings per share is 0.278 yuan.
The overall gross profit margin rose from 14.3% in the same period of 2024 to 14.5% in the first half of 2025. This was mainly due to an improvement in the gross profit margin of the clean energy and liquid food divisions, which offset the decline in the gross profit margin of the chemical and environmental divisions.
Related Articles

TYK MEDICINES-B(02410) and Sichuan Huiyu have entered into a potential exclusive distribution agreement for TY-9591.

Joinn Laboratories (06127) plans to invest no more than 10 million yuan to participate in the establishment of a biopharmaceutical fund.

HXTL (01085) released its interim results, showing a net loss attributable to shareholders of 70.42 million yuan, a year-on-year change from profit to loss.
TYK MEDICINES-B(02410) and Sichuan Huiyu have entered into a potential exclusive distribution agreement for TY-9591.

Joinn Laboratories (06127) plans to invest no more than 10 million yuan to participate in the establishment of a biopharmaceutical fund.

HXTL (01085) released its interim results, showing a net loss attributable to shareholders of 70.42 million yuan, a year-on-year change from profit to loss.

RECOMMEND

Analysts Respond to Trump’s Dismissal of Fed Governor Cook as a Further Assault on Central Bank Independence
26/08/2025

U.S. Proposes Including Copper, Silicon, Silver on 2025 Critical Minerals List Amid Supply Chain Concerns
26/08/2025

Trump Vows to Slash U.S. Drug Prices by Up to 1500%, Triggering Sell-Off in Pharma Stocks
26/08/2025